|
|
Press Kits
Download a Press KitContents may include press releases, digital images, and other background information.
Terms and Conditions
You may only use the material here for purposes of preparing news articles and reports regarding Eisai Inc. By downloading and copying the material contained herein, you agree not to:
- alter or distort any of the contents of the press kit
- use the material in any manner that implies a relationship with or endorsement by Eisai Inc.
- use the material in a manner that is misleading, defamatory, infringing, libelous, illegal, disparaging, obscene or otherwise objectionable to Eisai Inc., or impairing of the rights of Eisai Inc. in its trademarks or logos, in Eisai Inc.'s sole opinion.
Except as expressly provided herein, no right, title, license, or interest in any Eisai Inc. service marks, trademarks, or other material is intended to be given to or acquired through Eisai Inc.'s provision of the press kit.
| |
| Date Posted |
Description |
Download |
| |
| 5/30/2012 |
MORPHOTEK® EARNS PRESTIGIOUS AWARD
FOR INNOVATION... |
AAPS award Final.5 29.pdf |
| |
| 5/17/2012 |
Eisai Oncology to Present New Research on Product ... |
esi05172012.pdf |
| |
| 5/10/2012 |
Lorcaserin Receives Positive Vote From FDA Advisor... |
esi05102012b.pdf |
| |
| 5/10/2012 |
Arena and Eisai Expand Marketing and Supply Agreem... |
esi05102012.pdf |
| |
| 4/30/2012 |
Eisai Inc. Announces Appointment of Senior Vice Pr... |
esi04302012.pdf |
| |
| 4/20/2012 |
Eisai Amends License Agreement With Teikoku Pharma... |
esi04202012.pdf |
| |
| 4/18/2012 |
Neurology Publishes Results From Pivotal St... |
esi04182012.pdf |
| |
| 4/16/2012 |
Morphotek®, Inc. Announces Initiation of MORAb-004... |
mor04162012.pdf |
| |
| 3/27/2012 |
Morphotek®, Inc. Announces Completion of Enrollmen... |
mor03272012.pdf |
| |
| 3/7/2012 |
Eisai Inc. Receives Complete Response Letter from ... |
esi03062012.pdf |
| |
| 3/5/2012 |
FDA Accepts Resubmission of Perampanel New Drug Ap... |
esi03052012.pdf |
| |
| 2/10/2012 |
Statement Regarding FDA Oncologic Drugs Advisory C... |
esi02102012.pdf |
| |
| 2/2/2012 |
Arena Pharmaceuticals Receives Notice from FDA of ... |
esi02012012.pdf |
| |
| 1/30/2012 |
Eisai Increases its Commitment to Fight Neglected ... |
ecl01302012.pdf |
| |
| 1/10/2012 |
FDA Accepts Resubmission of Lorcaserin New Drug Ap... |
esi01102012.pdf |
| |
| 1/10/2012 |
Morphotek Enters Into Agreements With Fox Chase Ca... |
mor01102012.pdf |
| |
| 1/3/2012 |
Eisai Inc. Receives J-Code from CMS for Halaven® (... |
esi01032012.pdf |
| |
| 1/3/2012 |
Arena Submits Response to FDA Complete Response Le... |
esi01032012b.pdf |
| |
| 12/26/2011 |
Eisai Resubmits Perampanel (E2007) NDA to FDA |
esi12262011.pdf |
| |
| 12/15/2011 |
Eisai Announces Canadian Approval of its Anticance... |
ecl12152011.pdf |
| |
| 12/2/2011 |
Eisai Announces Commencement of Operations of a Ne... |
ecl12022011.pdf |
| |
| 12/1/2011 |
Eisai's Canadian Sales Subsidiary Celebrates O... |
ecl12012011.pdf |
| |
| 11/8/2011 |
Eisai Inc. and the Alzheimer's Association Hon... |
esi11082011.pdf |
| |
| 10/25/2011 |
University of Michigan Oncologist Receives Breast ... |
esi10252011.pdf |
| |
| 10/17/2011 |
Eisai Enters Into Neurological Drug Discovery Rese... |
ecl10172011.pdf |
| |
| 9/26/2011 |
New Data Analyses from Lorcaserin Phase 3 Clinical... |
09262011.pdf |
| |
| 9/23/2011 |
Helsinn Group and Eisai Inc. Announce Start of Pha... |
esi09232011.pdf |
| |
| 9/15/2011 |
Neglected Diseases in Developing Nations |
ecl09152011.pdf |
| |
| 9/7/2011 |
Eisai to Accelerate Late-Stage Clinical Developmen... |
ecl09072011.pdf |
| |
| 9/2/2011 |
Eisai Discontinues Global Development of Rabeprazo... |
esi09022011.pdf |
| |
| 8/30/2011 |
Results of Phase III Study for Perampanel Presente... |
esi08302011.pdf |
| |
| 8/16/2011 |
Eisai Establishes Subsidiary in Mexico |
esi08162011.pdf |
| |
| 8/9/2011 |
Arena and Eisai Announce Results of Re-Adjudicatio... |
esi08092011.pdf |
| |
| 8/2/2011 |
Arena and Eisai Announce Completion of Study Measu... |
esi08022011.pdf |
| |
| 7/29/2011 |
U.S. FDA Provides Response to Perampanel New Drug ... |
esi07292011.pdf |
| |
| 7/19/2011 |
Eisai Announces Japan Launch of Anticancer Agent H... |
ecl07192011.pdf |
| |
| 7/13/2011 |
Eisai Announces FDA Acceptance of sNDA Submission ... |
ESI07132011.pdf |
| |
| |
 Printer Friendly Version
|
|
|
